Bryan Johnson Blueprint Cost: $2M to $100 a Month

Last updated: June 2026

Quick answers

How much does Bryan Johnson’s Blueprint cost?

Bryan Johnson spends over $2 million per year on his full Blueprint longevity protocol, which covers a 30-person medical team, 100+ daily supplements, experimental therapies, and constant diagnostic testing. The consumer Blueprint supplement stack costs $361 per month. A DIY version replicating the evidence-backed core costs $55 to $90 per month in supplements.

Can you replicate Blueprint on a budget?

Yes. The blood work, diet, exercise, and sleep habits that make up the core of the program can be replicated for under $2,000 per year, according to Empirical Health’s analysis. The $2 million price tag pays for a concierge medical team and experimental therapies with limited human evidence.

What is Bryan Johnson’s Immortals program?

Immortals is a $1 million per year health program Johnson launched in February 2026, offering three clients his exact protocol. It includes a dedicated concierge team, the AI assistant BryanAI, extensive biomarker testing, and access to experimental therapies. Over 1,500 people applied within 30 hours of launch.

In 2013, Bryan Johnson sold Braintree, the payment processing company behind Venmo, to PayPal for $800 million in cash. He personally netted around $300 million from the deal. What he did next confused a lot of people in tech.

Instead of angel investing or launching another fintech company, Johnson turned his own body into a startup. He hired a team of 30 doctors and scientists, submitted every organ to measurement, and began running his biology like a product roadmap. He called it Blueprint. The spend: north of $2 million a year.

Bryan Johnson’s Blueprint protocol is a longevity regimen that combines diet, exercise, sleep optimization, 100+ daily supplements, prescription medications, and experimental therapies with the goal of slowing biological aging. Johnson reports aging at roughly 69% of the normal rate based on DunedinPACE testing and claims to rank first out of 5,677 competitors in the global Rejuvenation Olympics.

The numbers get attention. So does his Netflix documentary, Don’t Die: The Man Who Wants to Live Forever, which turned Johnson from a Silicon Valley curiosity into a mainstream figure. But the question most people actually search for isn’t “does it work?” It’s “how much does Bryan Johnson’s Blueprint cost, and what can I actually afford to copy?”

The answer depends entirely on which tier you’re looking at. And the gap between what Johnson spends and what the evidence actually supports spending is wider than most coverage of Blueprint acknowledges.

How much does Bryan Johnson spend on Blueprint?

Johnson’s total annual Blueprint spending exceeds $2 million. That figure has stayed consistent since he launched the project, though where the money goes has shifted as he drops interventions that don’t move his biomarkers.

The bulk of that spend goes to places most people can’t replicate and probably shouldn’t try. His 30-person medical team accounts for a major portion. Full-body MRIs, epigenetic age testing, constant blood panels, and experimental gene therapy (he received Follistatin gene therapy in Honduras in 2023, since it’s not FDA-approved in the U.S.) eat the rest. The food, exercise, and sleep habits that form the protocol’s backbone are not what costs $2 million. The constant medical surveillance and experimental interventions are.

Johnson himself pushed back on the $2 million framing in a 2023 post on X. “Blueprint doesn’t cost $2M a year,” he wrote. “It can be done for $1,684.50/month which includes food. Variations can be done for even less.” That’s roughly $20,200 per year for the protocol minus the medical team and experimental treatments.

Even that number overstates what most founders would need. The practical question isn’t what Johnson spends. It’s what the evidence actually supports spending.

Blueprint cost breakdown by tier

Blueprint operates on a spectrum from free to seven figures. Here’s what each tier actually includes and costs, based on Johnson’s published protocol and pricing from the Blueprint store.

The gap between tiers is staggering. The jump from DIY basics ($660/year) to Johnson’s personal spend ($2 million+/year) is a 3,000x difference. What separates them is mostly concierge medicine and experimental treatments with limited or no human evidence for longevity benefits.

What changed in the 2026 Blueprint protocol?

Johnson treats his body like a clinical trial subject. Every intervention gets tracked, measured, and dropped if the data stops supporting it. The 2026 update is his most significant revision yet, and the direction is interesting: he’s simplifying.

Rapamycin removed. This was one of Blueprint’s most discussed components. Rapamycin is an mTOR inhibitor that extended lifespan in mice in a 2009 study published in Nature. Johnson added it based on that animal data. In 2026, he dropped it after experiencing side effects. He hasn’t disclosed the specifics publicly, but rapamycin’s known risks include impaired wound healing, elevated blood lipids, increased infection susceptibility, and glucose disruption. If someone spending $2 million a year on health optimization with a full medical team monitoring every biomarker decides the risk-benefit ratio doesn’t work, that’s a meaningful signal for anyone considering it.

Low-dose lithium added. At micro-doses well below what’s prescribed for bipolar disorder, lithium has shown neuroprotective properties in observational research. A 2017 study in JAMA Psychiatry found that populations with higher trace lithium in drinking water showed lower rates of dementia. Johnson added it to target brain protection specifically.

NDGA added. Nordihydroguaiaretic acid is a lignan from the creosote bush. It extended lifespan in male mice in the National Institute on Aging’s Interventions Testing Program, one of the few rigorously controlled longevity studies in mammals. Human evidence remains thin.

NMN reduced to six days per week. Johnson previously took the NAD+ precursor daily. The shift reflects newer thinking that periodic breaks may prevent downregulation of the NAD+ salvage pathway, though the science here is still debated.

What is the Immortals program?

In February 2026, Johnson launched Immortals: three spots at $1 million per year for clients who want his exact protocol replicated for them. TechCrunch reported that the program includes a dedicated concierge team, 24/7 access to BryanAI (an AI assistant trained on Johnson’s protocol data), extensive biomarker testing, and access to experimental therapies.

The demand was real. Over 1,500 people applied in the first 30 hours, according to Axios. Inc. Magazine reported that people were “lining up” for the program.

Johnson has said lower-cost versions are coming: a $60,000 “supported” option and eventually a free digital version. The stated long-term goal is universal access regardless of income. That’s a familiar founder playbook: launch at the top of the market, use early revenue and data to build a product that scales down.

The business logic makes sense even if you’re skeptical of the science. Blueprint raised $60 million from backers including Kim Kardashian, Naval Ravikant, Alex Hormozi, Ari Emanuel, and the Winklevoss twins. Johnson hired Gyre Renwick as CEO so he could shift to vision and the broader Don’t Die movement. He’s building a longevity brand, not just running a personal experiment.

Can you do Blueprint on a budget?

Absolutely, and the science suggests you’ll capture most of the benefit. An analysis by Empirical Health broke down the Immortals protocol component by component and found that the highest-ROI parts cost under $2,000 per year total.

Here’s the practical version a founder could implement this week:

Free (just do these): Walk 8,000 to 10,000 steps daily. Resistance train two to three times per week. Sleep seven to eight hours on a consistent schedule. Stop eating three or more hours before bed. Cut alcohol. Get morning sunlight within 30 minutes of waking. Johnson himself has said that sleep optimization produced some of his most significant biomarker improvements.

$55-90 per month (evidence-backed supplements): Vitamin D3 at 2,000 to 5,000 IU daily ($8 to $12/month). Omega-3 fish oil with 2g EPA/DHA ($15 to $25/month). Magnesium glycinate at 200 to 400mg daily ($10 to $15/month). Creatine monohydrate at 5g daily ($10 to $15/month).

$190 to $400 per year (biomarker testing): This is where the real value lives. Comprehensive blood panels covering ApoB, Lp(a), hs-CRP, HbA1c, CBC, metabolic markers, and nutrient levels let you catch cardiovascular and metabolic problems decades before symptoms show up. Johnson’s obsessive testing is the one thing every longevity researcher agrees on: you can’t optimize what you don’t measure.

$300 to $500 one-time (wearable): An Apple Watch, Oura Ring, or Whoop gives you the same sleep, heart rate, and activity data streams Johnson uses daily.

Total annual cost for the DIY “sweet spot”: roughly $1,500 to $2,500. That captures the components with the broadest clinical evidence and skips the $999,000 worth of concierge medicine and experimental treatments.

Which parts of Blueprint actually work?

Not every piece of the protocol carries the same evidence. The honest breakdown, based on where the clinical research stands in 2026:

Strong evidence (do these regardless of budget): Regular exercise of 150+ minutes per week of moderate cardio plus two to three resistance sessions reduces all-cause mortality by 30% to 40%, according to a pooled analysis published in JAMA Internal Medicine. Consistent seven-to-eight-hour sleep has strong associations with cognitive health and longevity. A high-fiber, plant-rich diet with healthy fats improves cardiovascular and metabolic markers. No smoking and minimal alcohol remain the single largest preventable risk factors.

Moderate evidence (reasonable to consider): Creatine supplementation has a strong safety profile and benefits for both muscle and cognitive function. A 2018 study from the University of Sydney found that creatine improved short-term memory and reasoning in healthy adults. Time-restricted eating shows emerging metabolic benefits. Metformin for off-label aging use has positive observational data, with the TAME clinical trial (Targeting Aging with Metformin), led by Dr. Nir Barzilai at the Albert Einstein College of Medicine, still ongoing. CoQ10 supports mitochondrial function with some cardiovascular data behind it.

Weak or speculative (experimental): NDGA has mouse lifespan data only, from the National Institute on Aging’s Interventions Testing Program. Low-dose lithium for neuroprotection rests on epidemiological associations, including the 2017 JAMA Psychiatry study of Danish populations, but no randomized controlled trials exist for this specific use. NMN and NR at specific dosing frequencies lack conclusive human data on optimal protocols. A 2021 study in Science showed NMN improved muscle insulin sensitivity in prediabetic women, but longevity-specific outcomes remain unproven. Plasma exchange and gene therapy for longevity sit in the earliest experimental stages with no controlled human evidence.

The takeaway is uncomfortable for anyone selling a $1 million longevity program. The free stuff (exercise, sleep, diet) likely accounts for the vast majority of Johnson’s biological age improvements. The expensive interventions may contribute at the margins, but nobody has proven that yet, not even Johnson’s team with their hundreds of tracked biomarkers.

Peter Attia, the longevity physician and author of Outlive, has made a similar point: the four pillars of exercise, nutrition, sleep, and emotional health produce more measurable health improvement than any supplement or drug currently available. Johnson’s data, ironically, supports the same conclusion. His biggest biomarker jumps came from sleep optimization and consistent exercise, not from the experimental therapies that eat most of his budget.

The founder angle: Blueprint as a business

Johnson didn’t accidentally build a company. He did it the way serial founders operate: solve your own problem, document everything publicly, build an audience, then productize.

Blueprint’s trajectory follows a classic premium-to-mass playbook. Johnson started by spending his own money ($2 million-plus per year) on R&D, essentially funding the clinical development that a pharmaceutical company would spend tens of millions on. He open-sourced his protocol at protocol.bryanjohnson.com, building trust and a massive audience. Then he launched consumer products (the $361/month Blueprint Stack), a premium service (Immortals at $1 million), and raised $60 million in venture funding to scale it.

The Netflix documentary Don’t Die: The Man Who Wants to Live Forever added another growth vector. Johnson’s net worth sits around $400 million, according to multiple estimates. He doesn’t need the money. But he’s structured Blueprint like a venture-backed startup with a CEO (Gyre Renwick), outside investors, and a clear path from high-touch to self-serve.

For founders watching this, the lesson isn’t about longevity science. It’s about content-to-commerce. Johnson turned personal experimentation into a media brand, then a product line, then a high-ticket service, then a venture-backed company. The quantified-self movement keeps growing, and Johnson positioned himself at the center of it by being the most extreme, most transparent, and most documented participant.

The comparison to other founder-wellness brands is instructive. Dave Asprey built Bulletproof Coffee into a $234 million company using a similar playbook: personal biohacking story, product line, media presence. Johnson’s version is more extreme and more expensive, but the structure is identical. Build credibility through self-experimentation, document everything, and monetize the protocol once the audience trusts you.

Whether Blueprint’s science holds up long-term is a separate question from whether the business model works. Right now, both are performing. Johnson’s biological age metrics are impressive (even if the causation is debatable), and his company has $60 million in funding with multiple revenue streams. That’s a strong position regardless of which specific supplements actually move the needle on aging. For the average founder interested in longevity, the $55 to $90 per month DIY tier captures the most proven benefits without the financial commitment that only makes sense if you’ve already had an $800 million exit.

Written by Maya Reyes for GreyJournal. Have a story tip? Email editorial@greyjournal.net